Altogether, these data suggest that signaling from TNFR2 may trigger various direct or indirect anti-apoptotic pathways that can interact with each other to generate a highly complex apoptotic suppressive environment favoring BC growth and development. Here, TNFRSF1B is linked to breast cancer.